Oral Busulfan and Cyclophosphamide (BU/CY) versus Cyclophosphamide, Melphalan and Vepsid (Etoposide) (CMV) with Autologous Stem Cell Transplant in Patients with Relapsed Non-Hodgkin Lymphomas (NHL)
Ashraf Zedan, Raafat Abd EL Fattah, Abeer Ibrahim & Ahmed Mubarak · International Blood Research & Reviews · 2017
Background: High dose chemotherapy with autologous stem cell transplantation (ASCT) is the standard of care and commonly used procedure for patients with relapsed non Hodgkin lymphomas (NHL). There is no clear evidence of superior conditioning regimen and studies that comparing d...
Open access
Research Article
10.9734/IBRR/2017/35556